The Department of Transfusion Medicine has an initiative to produce Bone Marrow Stromal Cells (BMSCs) from healthy subjects which will be used to treat patients with a variety of conditions. Possible applications include treatment of acute graft versus host disease, marrow failure, organ failure following allogeneic stem cell transplantation, coronary artery disease, treatment of chronic graft versus host disease, inflammatory bowel disease, and multiple sclerosis.

Harvey G. Klein, M.D.
HKlein@cc.nih.gov
301.496.9702

http://clinicalcenter.nih.gov/dtm/
our_research.html#laboratory_services